BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30170357)

  • 1. The telomerase inhibitor MST-312 synergistically enhances the apoptotic effect of doxorubicin in pre-B acute lymphoblastic leukemia cells.
    Ghasemimehr N; Farsinejad A; Mirzaee Khalilabadi R; Yazdani Z; Fatemi A
    Biomed Pharmacother; 2018 Oct; 106():1742-1750. PubMed ID: 30170357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase inhibitor MST-312 induces apoptosis of multiple myeloma cells and down-regulation of anti-apoptotic, proliferative and inflammatory genes.
    Ameri Z; Ghiasi S; Farsinejad A; Hassanshahi G; Ehsan M; Fatemi A
    Life Sci; 2019 Jul; 228():66-71. PubMed ID: 31029779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cells.
    Bashash D; Zareii M; Safaroghli-Azar A; Omrani MD; Ghaffari SH
    Hematology; 2017 Jul; 22(6):330-340. PubMed ID: 28054503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial targeting of telomerase and DNA-PK induces synergistic apoptotic effects against Pre-B acute lymphoblastic leukemia cells.
    Katoueezadeh M; Maleki P; Torabizadeh SA; Farsinejad A; Khalilabadi RM; Valandani HM; Nurain IO; Ashoub MH; Fatemi A
    Mol Biol Rep; 2024 Jan; 51(1):163. PubMed ID: 38252348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MST-312 induces G2/M cell cycle arrest and apoptosis in APL cells through inhibition of telomerase activity and suppression of NF-κB pathway.
    Fatemi A; Safa M; Kazemi A
    Tumour Biol; 2015 Nov; 36(11):8425-37. PubMed ID: 26022158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RITA enhances chemosensivity of pre-B ALL cells to doxorubicin by inducing p53-dependent apoptosis.
    Kazemi A; Safa M; Shahbazi A
    Hematology; 2011 Jul; 16(4):225-31. PubMed ID: 21756539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of c-Myc using 10058-F4 exerts caspase-3-dependent apoptosis and intensifies the antileukemic effect of vincristine in pre-B acute lymphoblastic leukemia cells.
    Sheikh-Zeineddini N; Bashash D; Safaroghli-Azar A; Riyahi N; Shabestari RM; Janzamin E; Safa M
    J Cell Biochem; 2019 Aug; 120(8):14004-14016. PubMed ID: 30957273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of DNA-PK enhances chemosensitivity of B-cell precursor acute lymphoblastic leukemia cells to doxorubicin.
    Alikarami F; Safa M; Faranoush M; Hayat P; Kazemi A
    Biomed Pharmacother; 2017 Oct; 94():1077-1093. PubMed ID: 28821159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3K-δ inhibition using CAL-101 exerts apoptotic effects and increases doxorubicin-induced cell death in pre-B-acute lymphoblastic leukemia cells.
    Safaroghli-Azar A; Bashash D; Sadreazami P; Momeny M; Ghaffari SH
    Anticancer Drugs; 2017 Apr; 28(4):436-445. PubMed ID: 28125433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase inhibition by non-nucleosidic compound BIBR1532 causes rapid cell death in pre-B acute lymphoblastic leukemia cells.
    Bashash D; Ghaffari SH; Mirzaee R; Alimoghaddam K; Ghavamzadeh A
    Leuk Lymphoma; 2013 Mar; 54(3):561-8. PubMed ID: 22957790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tachykinin NK
    Bayati S; Bashash D; Ahmadian S; Safaroghli-Azar A; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Eur J Pharmacol; 2016 Nov; 791():274-283. PubMed ID: 27609608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising anti-leukemic effect of Zataria multiflora extract in combination with doxorubicin to combat acute lymphoblastic leukemia cells (Nalm-6) (in vitro and in silico).
    Lashkari M; Fatemi A; Valandani HM; Khalilabadi RM
    Sci Rep; 2022 Jul; 12(1):12657. PubMed ID: 35879400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin Induces Apoptosis in Pre-B Acute Lymphoblastic Leukemia Cell Lines Via PARP-1 Cleavage.
    Mishra D; Singh S; Narayan G
    Asian Pac J Cancer Prev; 2016; 17(8):3865-9. PubMed ID: 27644631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of cIAP-1 by novel antitubulin agents when combined with bryostatin 1 results in increased apoptosis in the human early pre-B acute lymphoblastic leukemia cell line Reh.
    Wall NR; Mohammad RM; Nabha SM; Pettit GR; Al-Katib AM
    Biochem Biophys Res Commun; 1999 Dec; 266(1):76-80. PubMed ID: 10581168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic apoptotic effect of Mcl-1 inhibition and doxorubicin on B-cell precursor acute lymphoblastic leukemia cells.
    Ebrahimi E; Shabestari RM; Bashash D; Safa M
    Mol Biol Rep; 2022 Mar; 49(3):2025-2036. PubMed ID: 35138523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of cAMP Levels Inhibits Doxorubicin-Induced Apoptosis in Pre- B ALL NALM- 6 Cells Through Induction of BAD Phosphorylation and Inhibition of P53 Accumulation.
    Fatemi A; Kazemi A; Kashiri M; Safa M
    Int J Mol Cell Med; 2015; 4(2):94-102. PubMed ID: 26261798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells.
    Tu HJ; Lin YJ; Chao MW; Sung TY; Wu YW; Chen YY; Lin MH; Liou JP; Pan SL; Yang CR
    Clin Epigenetics; 2018 Dec; 10(1):162. PubMed ID: 30594243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnosol delays chemotherapy-induced DNA fragmentation and morphological changes associated with apoptosis in leukemic cells.
    Zunino SJ; Storms DH
    Nutr Cancer; 2009; 61(1):94-102. PubMed ID: 19116879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory role of cAMP on doxorubicin-induced apoptosis in pre-B ALL cells through dephosphorylation of p53 serine residues.
    Safa M; Kazemi A; Zand H; Azarkeivan A; Zaker F; Hayat P
    Apoptosis; 2010 Feb; 15(2):196-203. PubMed ID: 19882354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indole-3-carbinol suppresses NF-κB activity and stimulates the p53 pathway in pre-B acute lymphoblastic leukemia cells.
    Safa M; Tavasoli B; Manafi R; Kiani F; Kashiri M; Ebrahimi S; Kazemi A
    Tumour Biol; 2015 May; 36(5):3919-30. PubMed ID: 25589462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.